Literature DB >> 16254064

The structure of negative symptoms within schizophrenia: implications for assessment.

Jack J Blanchard1, Alex S Cohen.   

Abstract

This review examines the structural validity of negative symptoms focusing on 2 questions: (1) Do negative symptoms represent a domain separate from other symptoms in schizophrenia? and (2) Within negative symptoms, is there a structure that suggests multidimensionality? Results from exploratory and confirmatory factor analytic studies are examined to address these questions. Across studies and symptom instruments, negative symptoms appear to consistently emerge as a factor separate from other dimensions of the illness in schizophrenia. Whether 2-, 3-, or 5-factor models are identified, negative symptoms consistently load on a factor separate from positive symptoms, affective symptoms of depression or anxiety, and symptoms of disorganization. Focusing on negative symptoms themselves, factor analytic findings suggest that this construct is multidimensional with at least 2 factors (involving diminished expression and anhedonia-asociality). Although these factors were replicable, serious limitations were noted in this literature. Thus, 2- (or even 3- or 5-) factor models of negative symptoms should not be considered definitive, but rather all converge to support the general conclusion of the multidimensionality of negative symptoms. The later findings indicate the importance of employing assessments that provide adequate coverage of the broad domain of negative symptoms. Importantly, caution is noted in the interpretability of findings based on existing instruments, and implications for future assessment are discussed.

Entities:  

Mesh:

Year:  2005        PMID: 16254064      PMCID: PMC2632211          DOI: 10.1093/schbul/sbj013

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  47 in total

1.  Is there a gender difference in a factorial structure of the positive and negative syndrome scale? A test by structural equation modeling.

Authors:  Naoki Hayashi; Yoshito Igarashi; Mitsuru Yamashina; Kiyoko Suda
Journal:  Psychopathology       Date:  2002 Jan-Feb       Impact factor: 1.944

Review 2.  How many and which are the psychopathological dimensions in schizophrenia? Issues influencing their ascertainment.

Authors:  V Peralta; M J Cuesta
Journal:  Schizophr Res       Date:  2001-04-30       Impact factor: 4.939

3.  A confirmatory factor analytic evaluation of the pentagonal PANSS model.

Authors:  Paul B Fitzgerald; Anthony R de Castella; Karren Brewer; Kate Filia; Jenny Collins; P Davey; T Rolfe; J Kulkarni
Journal:  Schizophr Res       Date:  2003-05-01       Impact factor: 4.939

4.  Five-factor model of schizophrenic psychopathology: how valid is it?

Authors:  L Lykouras; P Oulis; K Psarros; E Daskalopoulou; A Botsis; G N Christodoulou; C Stefanis
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2000       Impact factor: 5.270

Review 5.  A separate disease within the syndrome of schizophrenia.

Authors:  B Kirkpatrick; R W Buchanan; D E Ross; W T Carpenter
Journal:  Arch Gen Psychiatry       Date:  2001-02

Review 6.  The factor structure for the Positive and Negative Syndrome Scale (PANSS) in recent-onset psychosis.

Authors:  Robin Emsley; Jonathan Rabinowitz; Martijn Torreman
Journal:  Schizophr Res       Date:  2003-05-01       Impact factor: 4.939

7.  The expression and experience of emotion in schizophrenia: a study of social interactions.

Authors:  Minu A Aghevli; Jack J Blanchard; William P Horan
Journal:  Psychiatry Res       Date:  2003-08-01       Impact factor: 3.222

8.  Validity of symptom assessment in psychotic disorders: information variance across different sources of history.

Authors:  Beng-Choon Ho; Michael Flaum; William Hubbard; Stephan Arndt; Nancy C Andreasen
Journal:  Schizophr Res       Date:  2004-06-01       Impact factor: 4.939

9.  Symptoms of schizophrenia. Methods, meanings, and mechanisms.

Authors:  N C Andreasen; S Arndt; R Alliger; D Miller; M Flaum
Journal:  Arch Gen Psychiatry       Date:  1995-05

10.  Institutionalization and the defects of schizophrenia.

Authors:  E C Johnstone; D G Owens; A Gold; T J Crow; J F MacMillan
Journal:  Br J Psychiatry       Date:  1981-09       Impact factor: 9.319

View more
  205 in total

1.  Declining Clinical Course of Psychotic Disorders Over the Two Decades Following First Hospitalization: Evidence From the Suffolk County Mental Health Project.

Authors:  Roman Kotov; Laura Fochtmann; Kaiqiao Li; Marsha Tanenberg-Karant; Eduardo A Constantino; Joan Rubinstein; Greg Perlman; Eva Velthorst; Anne-Kathrin J Fett; Gabrielle Carlson; Evelyn J Bromet
Journal:  Am J Psychiatry       Date:  2017-08-04       Impact factor: 18.112

2.  The prospective relationships among intrinsic motivation, neurocognition, and psychosocial functioning in schizophrenia.

Authors:  Eri Nakagami; Maanse Hoe; John S Brekke
Journal:  Schizophr Bull       Date:  2010-05-12       Impact factor: 9.306

3.  The brief negative symptom scale: psychometric properties.

Authors:  Brian Kirkpatrick; Gregory P Strauss; Linh Nguyen; Bernard A Fischer; David G Daniel; Angel Cienfuegos; Stephen R Marder
Journal:  Schizophr Bull       Date:  2010-06-17       Impact factor: 9.306

Review 4.  Avolition and expressive deficits capture negative symptom phenomenology: implications for DSM-5 and schizophrenia research.

Authors:  Julie W Messinger; Fabien Trémeau; Daniel Antonius; Erika Mendelsohn; Vasthie Prudent; Arielle D Stanford; Dolores Malaspina
Journal:  Clin Psychol Rev       Date:  2010-09-18

5.  Abnormal responses to monetary outcomes in cortex, but not in the basal ganglia, in schizophrenia.

Authors:  James A Waltz; Julie B Schweitzer; Thomas J Ross; Pradeep K Kurup; Betty J Salmeron; Emma J Rose; James M Gold; Elliot A Stein
Journal:  Neuropsychopharmacology       Date:  2010-08-18       Impact factor: 7.853

6.  Self-Evaluation of Negative Symptoms: A Novel Tool to Assess Negative Symptoms.

Authors:  Sonia Dollfus; Cyril Mach; Rémy Morello
Journal:  Schizophr Bull       Date:  2015-11-12       Impact factor: 9.306

7.  The power to resist: the relationship between power, stigma, and negative symptoms in schizophrenia.

Authors:  Timothy R Campellone; Janelle M Caponigro; Ann M Kring
Journal:  Psychiatry Res       Date:  2013-11-26       Impact factor: 3.222

Review 8.  A meta-analytic review of self-reported, clinician-rated, and performance-based motivation measures in schizophrenia: Are we measuring the same "stuff"?

Authors:  Lauren Luther; Ruth L Firmin; Paul H Lysaker; Kyle S Minor; Michelle P Salyers
Journal:  Clin Psychol Rev       Date:  2018-04-07

9.  Comorbid depressive symptoms in the developmental course of adolescent-onset psychosis.

Authors:  Marina Myles-Worsley; Starla Weaver; Francisca Blailes
Journal:  Early Interv Psychiatry       Date:  2007-08-15       Impact factor: 2.732

10.  Further support for the role of dysfunctional attitudes in models of real-world functioning in schizophrenia.

Authors:  William P Horan; Yuri Rassovsky; Robert S Kern; Junghee Lee; Jonathan K Wynn; Michael F Green
Journal:  J Psychiatr Res       Date:  2009-12-14       Impact factor: 4.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.